Ontology highlight
ABSTRACT: Background
Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation.Objective
We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis patients.Methods
A retrospective review of the commercial database identified cardiac sarcoidosis patients who wore the wearable cardioverter defibrillator. Evidence for cardiac sarcoidosis diagnosis as well as demographic, co-morbidity and left ventricular ejection fraction were provided by patient clinical records. Clinical data also included daily wearable cardioverter defibrillator wear, shock treatment and survival information.Results
The wearable cardioverter defibrillator was worn by 46
SUBMITTER: Skowasch D
PROVIDER: S-EPMC5864098 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature